Increased H-FABP concentrations in nonalcoholic fatty liver disease Possible marker for subclinical myocardial damage and subclinical atherosclerosis


Basar O., AKBAL E., KOKLU S., Tuna Y., KOCAK E., Basar N., ...Daha Fazla

HERZ, cilt.38, sa.4, ss.417-422, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38 Sayı: 4
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s00059-012-3714-x
  • Dergi Adı: HERZ
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.417-422
  • Hacettepe Üniversitesi Adresli: Hayır

Özet

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder which is reported as the hepatic manifestation of metabolic syndrome with an increased risk of cardiovascular events. Patients with NAFLD are also at risk of future cardiac events independently of metabolic syndrome. The aim of this study was to examine serum concentrations of heart type fatty acid binding protein (H-FABP) in NAFLD and to investigate its correlations with metabolic parameters and subclinical atherosclerosis.